ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,571,000 | -15.8% | 90,238 | -47.1% | 0.01% | -17.6% |
| Q3 2014 | $6,619,000 | -75.8% | 170,459 | -78.6% | 0.02% | -45.2% |
| Q2 2014 | $27,388,000 | +644.8% | 795,370 | +834.7% | 0.03% | +287.5% |
| Q1 2014 | $3,677,000 | -93.2% | 85,098 | -93.7% | 0.01% | -93.4% |
| Q4 2013 | $54,231,000 | -18.8% | 1,361,230 | -23.5% | 0.12% | -21.4% |
| Q3 2013 | $66,807,000 | +17.9% | 1,779,609 | -15.6% | 0.15% | +17.6% |
| Q2 2013 | $56,649,000 | – | 2,108,266 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |